Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer
Authors:
- PANTOPRAZOLE‐DUODENAL ULCER‐STUDY GROUPPGPANTOPRAZOLE‐DUODENAL ULCER‐STUDY GROUP
- 1 February 1994
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 8 (1) , 81-86
Abstract
SUMMARY: Background:Pantoprazole is a new substituted benzimidazole that blocks the H+/K+‐ATPase in the gastric mucosa and thus inhibits acid secretion.Methods: Efficacy and tolerability of pantoprazole (40 mg at breakfast) and ranitidine (300 mg at bedtime) in the treatment of uncomplicated acute duodenal ulcer were compared in a double‐blind, randomized multicentre trial.Results:Of 202 outpatients who entered the study, 185 terminated the treatment without violation of the protocol. After 2 weeks of treatment, healing rates (protocol correct) with pantoprazole and ranitidine were 81 and 53%, respectively (P> 0.001), the corresponding results after 4 weeks were 97 and 83% (P> 0.01). Pantoprazole was more effective with respect to symptom relief. Both treatments were well tolerated.Conclusion:Pantoprazole 40 mg at breakfast is superior to ranitidine 300 mg at bedtime in the short‐term treatment of acute, uncomplicated duodenal ulcer.Keywords
This publication has 16 references indexed in Scilit:
- LansoprazoleDrugs, 1992
- Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: A double-blind, multicenter, 6-month studyGastroenterology, 1992
- Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulcerationAlimentary Pharmacology & Therapeutics, 1992
- Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazoleDigestive Diseases and Sciences, 1991
- A comparison of omeprazole and ranitidine for duodenal ulcer in South African patientsDigestive Diseases and Sciences, 1991
- Antisecretory therapy and genotoxicityDigestive Diseases and Sciences, 1991
- OmeprazoleNew England Journal of Medicine, 1991
- OmeprazoleDigestive Diseases and Sciences, 1991
- By 1023/SK&F 96022: Biochemistry of a novel (H+ + K+-ATPase inhibitorBiochemical Pharmacology, 1990
- Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.Gut, 1987